HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yutaro Kobayashi Selected Research

tryptophyl-histidine

7/2015The Anti-atherosclerotic Dipeptide, Trp-His, Reduces Intestinal Inflammation through the Blockade of L-Type Ca2+ Channels.
1/2012The anti-atherosclerotic di-peptide, Trp-His, inhibits the phosphorylation of voltage-dependent L-type Ca(2+) channels in rat vascular smooth muscle cells.
11/2010Trp-His, a vasorelaxant di-peptide, can inhibit extracellular Ca2+ entry to rat vascular smooth muscle cells through blockade of dihydropyridine-like L-type Ca2+ channels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yutaro Kobayashi Research Topics

Disease

3Atherosclerosis
01/2018 - 11/2010
2Infections
01/2021 - 06/2020
2Alzheimer Disease (Alzheimer's Disease)
01/2018 - 07/2016
2Hyperlipidemias (Hyperlipidemia)
01/2018 - 01/2018
2Body Weight (Weight, Body)
01/2018 - 07/2015
2Colitis
07/2015 - 02/2015
1Pruritus (Itching)
06/2020
1Virus Diseases (Viral Diseases)
06/2020
1Schizophrenia (Dementia Praecox)
01/2019
1Memory Disorders (Memory Loss)
01/2018
1Avian Reticuloendotheliosis
05/2016
1Inflammation (Inflammations)
07/2015
1Weight Loss (Weight Reduction)
02/2015
1Esophageal Neoplasms (Esophageal Cancer)
10/2002

Drug/Important Bio-Agent (IBA)

4Peptides (Polypeptides)IBA
01/2018 - 11/2010
3LipopolysaccharidesIBA
01/2018 - 07/2016
3tryptophyl-histidineIBA
07/2015 - 11/2010
2Amyloid (Amyloid Fibrils)IBA
01/2018 - 07/2016
2Drinking WaterIBA
01/2018 - 02/2015
2oxidized low density lipoproteinIBA
01/2018 - 01/2018
2CytokinesIBA
07/2015 - 02/2015
2Dextrans (Dextran)FDA Link
07/2015 - 02/2015
2sodium sulfate (sodium bisulfate)FDA LinkGeneric
07/2015 - 02/2015
1Poly I-CIBA
01/2021
1glecaprevir and pibrentasvirIBA
06/2020
1Serum AlbuminIBA
06/2020
1ErbB Receptors (EGF Receptor)IBA
01/2019
1Phosphotransferases (Kinase)IBA
01/2019
1Antipsychotic Agents (Antipsychotics)IBA
01/2019
1QuinazolinesIBA
01/2019
1Clozapine (Clozaril)FDA LinkGeneric
01/2019
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2018
1Apolipoproteins E (ApoE)IBA
01/2018
1monophosphoryl lipid AIBA
07/2016
1Toll-Like Receptors (Toll-Like Receptor)IBA
07/2016
1DipeptidesIBA
07/2015
1ConalbuminIBA
02/2015
1Biological ProductsIBA
11/2010
1Fluorouracil (Carac)FDA LinkGeneric
10/2002
1nedaplatinIBA
10/2002

Therapy/Procedure

3Oral Administration
01/2018 - 02/2015
1Renal Dialysis (Hemodialysis)
06/2020
1Therapeutics
06/2020
1Radiotherapy
10/2002
1Chemoradiotherapy
10/2002